Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)
1.125
+0.005 (0.45%)
At close: Jul 28, 2026
BIT:ERFO Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10 | 13 | 11 | 11 | 18 | - | |
Market Cap Growth | -12.70% | 16.03% | -4.14% | -38.34% | - | - |
Enterprise Value | 10.3 | 13.44 | 10.86 | 10.96 | 17.39 | 0 |
Last Close Price | 1.13 | 1.47 | 1.26 | 1.31 | 2.03 | - |
PE Ratio | 13.01 | 32.94 | 31.63 | 18.71 | 25.38 | - |
Forward PE | - | 12.78 | 19.46 | 13.10 | 12.30 | - |
PEG Ratio | - | 0.27 | 2.03 | 0.54 | - | - |
PS Ratio | 0.98 | 1.26 | 1.70 | 2.08 | 3.64 | - |
PB Ratio | 1.14 | 1.55 | 1.38 | 1.39 | 2.30 | - |
P/TBV Ratio | 1.65 | 2.16 | 2.09 | 2.14 | 3.56 | - |
P/FCF Ratio | 11.27 | 13.64 | 8.70 | 11.70 | 66.67 | - |
P/OCF Ratio | 10.43 | 13.64 | 8.70 | 8.89 | 26.51 | - |
EV/Sales Ratio | 1.06 | 1.35 | 1.71 | 2.02 | 3.47 | - |
EV/EBITDA Ratio | 5.41 | 7.06 | 8.96 | 7.60 | 10.51 | - |
EV/EBIT Ratio | 10.38 | 13.55 | 20.72 | 13.79 | 16.76 | - |
EV/FCF Ratio | 12.12 | 14.63 | 8.75 | 11.38 | 63.47 | - |
Debt / Equity Ratio | 0.17 | 0.17 | 0.05 | 0.06 | 0.07 | 0.16 |
Debt / EBITDA Ratio | 0.71 | 0.71 | 0.31 | 0.31 | 0.35 | 0.37 |
Debt / FCF Ratio | 1.52 | 1.47 | 0.30 | 0.47 | 2.12 | 0.36 |
Net Debt / Equity Ratio | 0.11 | 0.11 | 0.01 | -0.04 | -0.11 | 0.08 |
Net Debt / EBITDA Ratio | 0.48 | 0.48 | 0.05 | -0.21 | -0.53 | 0.19 |
Net Debt / FCF Ratio | 1.02 | 0.99 | 0.05 | -0.32 | -3.20 | 0.18 |
Asset Turnover | 0.96 | 0.96 | 0.63 | 0.52 | 0.57 | 0.70 |
Inventory Turnover | -2.72 | -2.72 | -1.69 | 1.63 | 1.66 | 2.14 |
Quick Ratio | 0.74 | 0.74 | 0.63 | 0.91 | 1.02 | 0.55 |
Current Ratio | 1.67 | 1.67 | 1.50 | 1.89 | 2.05 | 1.09 |
Return on Equity (ROE) | 9.25% | 9.25% | 4.43% | 7.28% | 11.90% | 22.13% |
Return on Assets (ROA) | 6.99% | 9.54% | 5.24% | 5.78% | 8.89% | 16.20% |
Return on Invested Capital (ROIC) | 8.07% | 11.74% | 6.69% | 8.05% | 12.87% | 21.96% |
Return on Capital Employed (ROCE) | 11.17% | 11.17% | 6.16% | 9.23% | 14.77% | 26.29% |
Earnings Yield | 7.69% | 3.04% | 3.16% | 5.34% | 3.94% | - |
FCF Yield | 8.87% | 7.33% | 11.49% | 8.55% | 1.50% | - |
Dividend Yield | - | 0.00% | 0.00% | 1.41% | 3.01% | - |
Payout Ratio | - | 0.00% | 0.00% | 28.46% | 72.91% | 185.74% |
Buyback Yield / Dilution | 0.68% | -0.60% | 5.56% | 0.00% | -500.00% | - |
Total Shareholder Return | 0.68% | -0.60% | 5.56% | 1.41% | -496.99% | - |